Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
about
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerQuantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometryLimited clinical value of periablative changes of serum markers in the prediction of biochemical remission in patients with papillary thyroid cancerCurrent concepts and future directions in differentiated thyroid cancer.Effect of exogenous circulating anti-bPL antibodies on bovine placental lactogen measurements in foetal samplesComparison of the Influence on the Liver Function Between Thyroid Hormone Withdrawal and rh-TSH Before High-Dose Radioiodine Therapy in Patients with Well-Differentiated Thyroid Cancer.Definition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry guidelines: comparison of eleven different automated methodsThyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paperSerial stimulated thyroglobulin measurements are more specific for detecting distant metastatic differentiated thyroid cancer before radioiodine therapy.The influence of prior hyperthyroidism on euthyroid graves' ophthalmopathy.Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancerThyroglobulin as a biomarker of iodine deficiency: a review.How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodiesPhase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.Interferences in immunoassay.Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.The role of autoimmune testing in chronic idiopathic urticaria.Thyroglobulin antibody resolution after total thyroidectomy for cancer.Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma.Management of thyroid cancers.A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma.Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma.Protein target quantification decision tree.Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry.Estimation of true serum thyroglobulin concentration using simultaneous measurement of serum antithyroglobulin antibody.Postoperative stimulated thyroglobulin level and recurrence risk stratification in differentiated thyroid cancer.Approach to follow-up of the patient with differentiated thyroid cancer and positive anti-thyroglobulin antibodies.Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer.The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry.Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors.Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.Well-differentiated thyroid carcinomas: management of the central lymph node compartment and emerging biochemical markers.Anti-thyroglobulin antibodies do not significantly increase the risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients.Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer.The Role of Intraoperative Thyroglobuline Level of Lymph Node in the Management of Papillary Thyroid Cancer (Determination of a Cutoff Point).Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
P2860
Q26829349-DA063EC2-5EC6-41EC-942F-2C25CCF022FDQ30367068-0C0AF282-ABC2-4900-B12C-81B7CB7C2E49Q33370510-E115B555-3766-4402-BF27-B038A5BEB56DQ33669903-37C313D0-7D40-4499-8D89-8EE65A4A9CBBQ33677589-C07E62F9-6D0C-404C-90B3-193E8B09F290Q33698607-51393C0B-2D99-443E-8D9F-6F0B26F6AB4CQ33704312-1E5BDF39-3E2E-43FB-8C6B-0D37994C971AQ33812382-1C63321E-CAA3-4C7B-B542-7B7C4BFC9B5DQ33825202-43CD8B8B-ED41-492E-87D5-F44B55F55563Q33871894-76CC8EAD-7FE6-4279-B80A-FDA40655B876Q33876359-01786E35-D702-449E-BEAC-D13EDFCD46C7Q33919186-55F0EFCA-DF3B-4948-B2DD-E871416CB3A1Q33931462-4A4BA629-391C-4206-BA94-551DC2E290D0Q34134307-D479F92C-A2F5-4548-97A2-2B7ADA2E0F88Q34714310-3EC0EA85-9DDB-4C24-A332-E05C97BD180FQ34776072-9C432E33-44FB-49ED-BD09-2FC1005BB76CQ35916507-90CB1B19-5C39-4766-93E4-3EEFACF6200BQ35923496-0BAB0BF3-4227-4DE0-BBC3-B03E43633CC6Q36030813-3FB0D77E-F2A2-4B5E-B232-CEFAB86191ECQ36031629-C4080B0A-C282-41D9-8899-DC24C8664E9AQ36064573-A4229E79-98E5-4955-BC70-6A8D1ECF27AAQ36170027-E7C96C06-1DC0-4F7D-812F-BF83CA984456Q36196615-EB295042-9353-4E23-B048-D9362D2B7517Q36233648-BCAA8DA9-ECDA-4BB9-AF45-CCBE0109A80CQ36265557-1EF44DA8-A4CC-44B8-A4E6-19C01027A878Q36582456-3E1B8539-3F63-4CD8-AD74-CF617A52DAA7Q36736452-A7E56F1C-1687-4C21-AEA7-B07698195187Q36765555-EC440150-5835-4CB8-9428-FC84F043B274Q36801435-6AAAA678-F41D-4A3B-A813-AF0234B4C9E3Q37071232-7EC07D0C-139A-455B-A8DB-0FDAF2EFE0A1Q37084125-57064044-1E1B-4C22-9259-04942CA7C5F1Q37286989-DDD8F61B-8417-43E3-A0B2-97EA4FF61901Q37460181-A2BAA82E-9A6C-4473-8BDA-8371684B5956Q37725502-860D8BA2-A37C-4E50-BDA8-DEB95C6DE761Q37736235-2B56FD94-FADC-4D9A-8DE0-67515A122717Q38587701-E8B0A00D-7AAB-46D2-998B-36A8F5248433Q38783065-1680879E-14AC-4569-ACB8-5507284994CBQ41050094-ABAA9EE3-137E-4729-88F0-6E7CFCDB00C1Q41608843-497CC854-B6C9-4EB5-A2B0-36AD266C5B92Q41772758-E5854578-B037-41D9-840B-93138C1B103D
P2860
Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Serum thyroglobulin autoantibo ...... ferentiated thyroid carcinoma.
@en
Serum thyroglobulin autoantibo ...... ferentiated thyroid carcinoma.
@nl
type
label
Serum thyroglobulin autoantibo ...... ferentiated thyroid carcinoma.
@en
Serum thyroglobulin autoantibo ...... ferentiated thyroid carcinoma.
@nl
prefLabel
Serum thyroglobulin autoantibo ...... ferentiated thyroid carcinoma.
@en
Serum thyroglobulin autoantibo ...... ferentiated thyroid carcinoma.
@nl
P2093
P356
P1476
Serum thyroglobulin autoantibo ...... ferentiated thyroid carcinoma.
@en
P2093
Guttler RB
Kazarosyan M
LoPresti JS
Nicoloff JT
Spencer CA
Takeuchi M
P304
P356
10.1210/JCEM.83.4.4683
P407
P577
1998-04-01T00:00:00Z